These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 32496457)

  • 1. Central Nervous System Lymphoma: Approach to Diagnosis and Treatment.
    Correia CE; Schaff LR; Grommes C
    Cancer J; 2020; 26(3):241-252. PubMed ID: 32496457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary CNS Lymphoma.
    Grommes C; DeAngelis LM
    J Clin Oncol; 2017 Jul; 35(21):2410-2418. PubMed ID: 28640701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in Primary Central Nervous System Lymphoma.
    Patrick LB; Mohile NA
    Curr Oncol Rep; 2015 Dec; 17(12):60. PubMed ID: 26475775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of primary central nervous system lymphoma.
    Ekenel M; DeAngelis LM
    Curr Neurol Neurosci Rep; 2007 May; 7(3):191-9. PubMed ID: 17488584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
    Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
    Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis, prognosis and treatment of primary central nervous system lymphoma in the elderly population (Review).
    Liu Y; Yao Q; Zhang F
    Int J Oncol; 2021 Mar; 58(3):371-387. PubMed ID: 33650642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concomitant systemic and central nervous system non-Hodgkin lymphoma: the role of consolidation in terms of high dose therapy and autologous stem cell transplantation. A 60-case retrospective study from LYSA and the LOC network.
    Damaj G; Ivanoff S; Coso D; Ysaebert L; Choquet S; Houillier C; Parcelier A; Abarah W; Marjanovic Z; Gressin R; Garidi R; Diouf M; Gac AC; Dupuis J; Troussard X; Morschhauseur F; Ghesquières H; Soussain C;
    Haematologica; 2015 Sep; 100(9):1199-206. PubMed ID: 26185174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of Primary CNS Lymphoma: Maximizing Clinical Benefit, Minimizing Neurotoxicity.
    Song KW; Batchelor T
    Curr Oncol Rep; 2021 Sep; 23(11):132. PubMed ID: 34524547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of newly diagnosed primary central nervous system lymphoma: current and emerging therapies.
    Sethi TK; Reddy NM
    Leuk Lymphoma; 2019 Jan; 60(1):6-18. PubMed ID: 29741421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haematopoietic stem cell transplantation for treatment of primary CNS lymphoma: single-centre experience and literature review.
    Bojic M; Berghoff AS; Troch M; Agis H; Sperr WR; Widhalm G; Wöhrer A; Kalhs P; Preusser M; Rabitsch W
    Eur J Haematol; 2015 Jul; 95(1):75-82. PubMed ID: 25546348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis and management of primary central nervous system lymphoma.
    Han CH; Batchelor TT
    Cancer; 2017 Nov; 123(22):4314-4324. PubMed ID: 28950405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary Central Nervous System Lymphoma: Evolving Biologic Insights and Recent Therapeutic Advances.
    Chihara D; Dunleavy K
    Clin Lymphoma Myeloma Leuk; 2021 Feb; 21(2):73-79. PubMed ID: 33288483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central Nervous System Lymphoma.
    Shah T; Venur VA
    Semin Neurol; 2023 Dec; 43(6):825-832. PubMed ID: 37995744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic management of refractory or relapsed primary central nervous system lymphomas.
    Reni M; Ferreri AJ
    Ann Hematol; 2001; 80 Suppl 3():B113-7. PubMed ID: 11757691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5. Report on workshop: Primary CNS lymphoma.
    Korfel A; Finke J; Schmidt-Wolf I; Thiel E
    Ann Hematol; 2001; 80 Suppl 3():B20-3. PubMed ID: 11757699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary central nervous system lymphoma: overview of current treatment strategies.
    Brastianos PK; Batchelor TT
    Hematol Oncol Clin North Am; 2012 Aug; 26(4):897-916. PubMed ID: 22794289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic delay and outcome in immunocompetent patients with primary central nervous system lymphoma in Spain: a multicentric study.
    Velasco R; Mercadal S; Vidal N; Alañá M; Barceló MI; Ibáñez-Juliá MJ; Bobillo S; Caldú Agud R; García Molina E; Martínez P; Cacabelos P; Muntañola A; García-Catalán G; Sancho JM; Camro I; Lado T; Erro ME; Gómez-Vicente L; Salar A; Caballero AC; Solé-Rodríguez M; Gállego Pérez-Larraya J; Huertas N; Estela J; Barón M; Barbero-Bordallo N; Encuentra M; Dlouhy I; Bruna J; Graus F;
    J Neurooncol; 2020 Jul; 148(3):545-554. PubMed ID: 32524392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial.
    Ferreri AJ; Cwynarski K; Pulczynski E; Ponzoni M; Deckert M; Politi LS; Torri V; Fox CP; Rosée PL; Schorb E; Ambrosetti A; Roth A; Hemmaway C; Ferrari A; Linton KM; Rudà R; Binder M; Pukrop T; Balzarotti M; Fabbri A; Johnson P; Gørløv JS; Hess G; Panse J; Pisani F; Tucci A; Stilgenbauer S; Hertenstein B; Keller U; Krause SW; Levis A; Schmoll HJ; Cavalli F; Finke J; Reni M; Zucca E; Illerhaus G;
    Lancet Haematol; 2016 May; 3(5):e217-27. PubMed ID: 27132696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary CNS lymphoma.
    Gerstner E; Batchelor T
    Expert Rev Anticancer Ther; 2007 May; 7(5):689-700. PubMed ID: 17492932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of chemotherapy additional to high-dose methotrexate for primary central nervous system lymphoma (PCNSL).
    Bergner N; Monsef I; Illerhaus G; Engert A; Skoetz N
    Cochrane Database Syst Rev; 2012 Nov; 11():CD009355. PubMed ID: 23152274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.